Bovie Medical Corporation Appoints Chief Financial Officer

Bovie Medical Corporation has appointed Tara H. Semb as chief financial officer (CFO), effective Jan. 2.
 
“I am pleased to announce the appointment of Tara Semb, who joins the executive leadership team at Bovie Medical with a strong background in financial and operational business process and internal controls,” said Charlie Goodwin, president and CEO. “Ms. Semb’s career history includes executive level experience as the chief financial officer for a rapidly growing company in the consumer market, and she has also held senior positions on the finance team at a large, diversified global manufacturing company with significant commercial scale and profitability. I look forward to working closely with her as we continue to position Bovie Medical for its next stage of growth.”
 
Prior to joining Bovie Medical, Semb was CFO for AVAIL Vapor LLC, a manufacturer and retailer of e-liquid for use in electronic vapor devices, from 2015 until 2018. Semb previously worked for Amsted Industries, a diversified global manufacturer of industrial components, in multiple positions of increasing responsibility from 2006 until 2015, culminating in her promotion to director of Finance for the company’s rail bearings division in 2013. Before joining Amsted Industries as director of Internal Audit in 2006, she held financial and operational roles at Blyth Industries, a manufacturer and seller of candles and home fragrance products, and Anixter International, a global distributor of network and security solutions. She began her career in 1991 as an auditor at Price Waterhouse.
 
Semb has a bachelor of science degree in accounting from the University of Illinois, as well as an MBA from Washington University in St. Louis. She is a certified public accountant.

“Bovie Medical is an impressive organization with a compelling growth opportunity in the cosmetic surgery market,” said Semb. “I am excited to join the company at a time that I believe represents an important inflection point in its history and look forward to partnering with Charlie and the rest of the executive leadership team.”
 
Bovie Medical Corporation is a maker of medical devices and supplies as well as the developer of J-Plasma (marketed and sold under the Renuvion Cosmetic Technology brand in the cosmetic surgery market), a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma technology utilizes a helium ionization process to produce a stable, focused beam of plasma that provides surgeons with greater precision, and minimal invasiveness. The new J-Plasma handpieces with Cool-Coag technology deliver the precision of helium plasma energy, the power of traditional monopolar coagulation and the efficiency of plasma beam coagulation— enabling thin-layer ablation and dissection and fast coagulation with a single instrument, minimizing instrument exchange and allowing a surgeon to focus on their patient and their procedures. With Cool-Coag technology, the new J-Plasma handpieces can deliver three distinctly different energy modalities— further increasing the utility and versatility of the system. The company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers.